Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study

Autor: Dobesh, Paul P., Fermann, Gregory J., Christoph, Mary J., Koch, Bruce, Lesén, Eva, Chen, Hungta, Lovelace, Belinda, Dettling, Theresa, Danese, Mark, Ulloa, Julie, Danese, Sherry, Coleman, Craig I.
Zdroj: In Research and Practice in Thrombosis and Haemostasis August 2023 7(6)
Databáze: ScienceDirect
Externí odkaz: